Travere Therapeutics, Inc. (TVTX)
30.22
-0.10
(-0.33%)
USD |
NASDAQ |
Feb 11, 16:00
30.46
+0.24
(+0.79%)
Pre-Market: 08:00
Travere Therapeutics Profit Margin (Quarterly) : 15.59% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 27.89% |
| Ligand Pharmaceuticals, Inc. | -- |
| Plus Therapeutics, Inc. | -316.6% |
| BioStem Technologies, Inc. | 7.27% |
| Iovance Biotherapeutics, Inc. | -135.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -263.9% |
| Return on Assets | -16.15% |
| Return on Invested Capital | -21.07% |
| Gross Profit Margin (Quarterly) | 89.46% |
| Operating Margin (Quarterly) | 15.12% |
| Return on Net Operating Assets | -51.86% |